Allena Pharma (NASDAQ: ALNA)
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-11-09 | ||||||
REV |
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-23 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Allena Pharma (NASDAQ: ALNA) through any online brokerage.
Other companies in Allena Pharma’s space includes: Immuron (NASDAQ:IMRN), Midatech Pharma (NASDAQ:MTP), Cyclacel Pharmaceuticals (NASDAQ:CYCC), Biophytis (NASDAQ:BPTS) and Diffusion Pharmaceuticals (NASDAQ:DFFN).
The latest price target for Allena Pharma (NASDAQ: ALNA) was reported by B. Riley Securities on Tuesday, March 22, 2022. The analyst firm set a price target for 0.50 expecting ALNA to rise to within 12 months (a possible 278.21% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Allena Pharma (NASDAQ: ALNA) is $0.1322 last updated Today at August 9, 2022, 2:10 PM UTC.
There are no upcoming dividends for Allena Pharma.
Allena Pharma’s Q3 earnings are confirmed for Wednesday, November 9, 2022.
There is no upcoming split for Allena Pharma.
Allena Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.